Recent News for SPRO - Spero Therapeutics, Inc.

Date Title
Aug 8 Spero Therapeutics' (SPRO) CEO Ankit Mahadevia on Q2 2020 Results - Earnings Call Transcript
Aug 7 Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Lags Revenue Estimates
Aug 6 Spero Therapeutics EPS beats by $0.28, misses on revenue
Aug 6 Spero Therapeutics Announces Second Quarter 2020 Operating Results and Provides Business Update
Aug 6 The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
Aug 2 The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Jul 30 Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for
Jul 29 Spero Therapeutics to Provide Business Update and Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Jun 24 The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact
Jun 23 The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
Jun 15 Is Spero Therapeutics, Inc. (SPRO) Going to Burn These Hedge Funds?
Jun 8 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spero Therapeutics, Inc. - SPRO
Jun 4 Spero Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm
Jun 2 10 Tax Tips for Airbnb, HomeAway & VRBO Vacation Rentals
Jun 1 Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
May 28 SPERO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm
May 27 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  Spero Therapeutics, Inc. - SPRO
May 25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spero Therapeutics, Inc. - SPRO
May 13 Spero Therapeutics (SPRO) Presents At Bank of America Healthcare Virtual Conference 2020 - Slideshow
May 13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  Spero Therapeutics, Inc. - SPRO
May 12 SPRO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spero Therapeutics, Inc. and Encourages Investors to Contact the Firm
May 12 Spero Therapeutics, Inc. (SPRO) Q1 2020 Earnings Call Transcript
May 12 Spero Therapeutics, Inc. (SPRO) Shares March Higher, Can It Continue?
May 12 Spero Therapeutics, Inc. (SPRO) CEO Dr. Ankit Mahadevia on Q1 2020 Results - Earnings Call Transcript
May 11 H.C. Wainwright Sticks to Their Buy Rating for Spero Therapeutics Inc
Back to the Main SPRO Page...